Does Rallies show Form 4 insider transactions for EOLS?

Yes. Rallies tracks EOLS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is EOLS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EOLS. It does not provide personalized investment advice.

EOLS (Evolus, Inc. Common Stock) Stock Analysis - Insider Trades

Evolus, Inc. Common Stock (EOLS) is a publicly traded Healthcare sector company. As of May 21, 2026, EOLS trades at $6.59 with a market cap of $432.67M and a P/E ratio of -9.80. EOLS moved +2.26% today. Year to date, EOLS is +8.93%; over the trailing twelve months it is -33.84%. Its 52-week range spans $3.86 to $17.82. Analyst consensus is strong buy with an average price target of $14.50. Rallies surfaces EOLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading EOLS stock inside the company?

Recent EOLS insider activity includes Avelar Rui sold 3.12K, MOATAZEDI DAVID sold 13.67K, MOATAZEDI DAVID sold 116.72K, Avelar Rui sold 30.00K, and MOATAZEDI DAVID sold 10.54K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

EOLS Key Metrics

Key financial metrics for EOLS
Metric	Value
Price	$6.59
Market Cap	$432.67M
P/E Ratio	-9.80
EPS	$-0.67
Dividend Yield	0.00%
52-Week High	$17.82
52-Week Low	$3.86
Volume	112
Avg Volume	0
Revenue (TTM)	$301.79M
Net Income	$-43.42M
Gross Margin	66.06%

Recent EOLS Insider Trades

Avelar Rui sold 3.12K (~$14.82K) on Mar 20, 2026.
MOATAZEDI DAVID sold 13.67K (~$64.93K) on Mar 20, 2026.
MOATAZEDI DAVID sold 116.72K (~$570.56K) on Mar 17, 2026.
Avelar Rui sold 30.00K (~$146.63K) on Mar 17, 2026.
MOATAZEDI DAVID sold 10.54K (~$75.36K) on Dec 22, 2025.

Latest EOLS News

Revance CEO outlines sales force expansion to boost DAXXIFY growth — Apr 7, 2026
Evolus Q4 Revenue Climbs 14% to $90.3M, 2026 Guide Set at $327–337M — Mar 4, 2026
Evolus Expects Q4 EPS $0.06, Revenue $89.4M; Mizuho Cuts Target to $15 — Feb 26, 2026

EOLS Analyst Consensus

5 analysts cover EOLS: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.50.

Common questions about EOLS

Who is trading EOLS stock inside the company?: Recent EOLS insider activity includes Avelar Rui sold 3.12K, MOATAZEDI DAVID sold 13.67K, MOATAZEDI DAVID sold 116.72K, Avelar Rui sold 30.00K, and MOATAZEDI DAVID sold 10.54K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for EOLS?: Yes. Rallies tracks EOLS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is EOLS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EOLS. It does not provide personalized investment advice.